Risankizumab for Fibrostenotic Crohn's Disease Treatment

NCT07177118 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

260

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease
Crohn Disease and Ulcerative Colitis

Interventions

DRUG: Ustekinumab
DRUG: Risankizumab

Sponsor

First Affiliated Hospital of Wenzhou Medical University

Collaborators

[object Object]
[object Object]